Retrospective audit of inter-fraction motion for pelvic node radiotherapy in prostate cancer patients

被引:4
作者
Lawes, R. [1 ]
Carter, E. [1 ]
Hussein, M. [1 ]
Murray, J. [1 ,2 ,3 ]
McNair, H. A. [1 ,3 ]
机构
[1] Royal Marsden NHS Fdn Trust, Radiotherapy, Sutton, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Acad Urol Unit, Sutton, Surrey, England
[3] Inst Canc Res, Sutton, Surrey, England
关键词
Prostate cancer; Lymph nodes; Margins; Radiation therapy; RADIATION-THERAPY;
D O I
10.1016/j.radi.2020.08.002
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Pelvic lymph nodes move independently to the prostate. When delivering radiotherapy to prostate and pelvic lymph nodes, daily inter- and intra-fraction anatomical changes need to be accounted for. Planning target volume (PTV) margins, grown from the pelvic lymph node clinical target volume need to be determined, to account for this variation in position. Methods: Twenty patients who had daily online image guided radiotherapy to prostate and pelvic lymph nodes between April and December 2018 were selected. Ten pre-treatment verification images using cone beam CT from each patient were registered to pelvic bone anatomy, prostate soft tissue or fiducial markers and pelvic lymph node soft tissue to assess the accuracy of treatment delivery. Population systematic and random errors and PTV margins were calculated. Results: PTV margins of 0.4 cm, 0.4 cm and 0.7 cm lefteright (LR), superioreinferior (SI) and anterior -posterior (AP) respectively were derived for the pelvic lymph nodes when registering to prostate. PTV margins of 0.3 cm, 0.2 cm and 0.4 cm LR, SI and AP respectively were derived for the pelvic lymph nodes when registering to bone. There was a posterior systematic shift of the prostate during the treatment course. Conclusion: There is differential motion of pelvic lymph nodes to prostate and in the era of prostate and pelvic radiotherapy for patients with node positive prostate cancer; there is increasing importance in the accuracy of dose delivery to the involved lymph node. Hence, this group of patients may benefit from personalised radiotherapy PTV margins, especially if the involved pelvic lymph node is within the anterior part of the clinical target volume. Implications for practice: Optimisation of dose delivery to the pelvic lymph nodes when prioritising the prostate in prostate and pelvic lymph node image guided radiotherapy. Crown Copyright (c) 2020 Published by Elsevier Ltd on behalf of The College of Radiographers. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:266 / 271
页数:6
相关论文
共 17 条
  • [1] Image-guided radiotherapy for prostate cancer in the United Kingdom: a national survey
    Ariyaratne, Hemal
    Chesham, Hayley
    Alonzi, Roberto
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070)
  • [2] Image-guided radiotherapy for prostate cancer
    Dang, Audrey
    Kupelian, Patrick A.
    Cao, Minsong
    Agazaryan, Nzhde
    Kishan, Amar U.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 308 - 320
  • [3] Dufton J, 2017, EUR J SURG ONCOL, V43, P2219
  • [4] Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?
    Eminowicz, G.
    Dean, C.
    Shoffren, O.
    MacDougall, N.
    Wells, P.
    Muirhead, R.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2014, 87 (1037)
  • [5] Intensity-modulated radiotherapy for prostate cancer
    Fischer-Valuck, Ben W.
    Rao, Yuan James
    Michalski, Jeff M.
    [J]. TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 (03) : 297 - 307
  • [6] Image Guidance in Radiation Therapy: Techniques and Applications
    Goyal, Shikha
    Kataria, Tejinder
    [J]. RADIOLOGY RESEARCH AND PRACTICE, 2014, 2014
  • [7] Groher M, 2017, STRAHLENTHER ONKOL, V193, P750, DOI 10.1007/s00066-017-1182-1
  • [8] Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy
    Harris, Victoria A.
    Staffurth, John
    Naismith, Olivia
    Esmail, Alikhan
    Gulliford, Sarah
    Khoo, Vincent
    Lewis, Rebecca
    Littler, John
    McNair, Helen
    Sadoyze, Azmat
    Scrase, Christopher
    Sohaib, Aslam
    Syndikus, Isabel
    Zarkar, Anjali
    Hall, Emma
    Dearnaley, David
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 92 (04): : 874 - 883
  • [9] A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes
    Hsu, Annie
    Pawlicki, Todd
    Luxton, Gary
    Hara, Wendy
    King, Christopher R.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (03): : 898 - 902
  • [10] Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer Data From Patients in the Control Arm of the STAMPEDE Trial
    James, Nicholas D.
    Spears, Melissa R.
    Clarke, Noel W.
    Dearnaley, David P.
    Mason, Malcolm D.
    Parker, Christopher C.
    Ritchie, Alastair W. S.
    Russell, J. Martin
    Schiavone, Francesca
    Attard, Gerhardt
    de Bono, Johann S.
    Birtle, Alison
    Engeler, Daniel S.
    Elliott, Tony
    Matheson, David
    O'Sullivan, Joe
    Pudney, Delia
    Srihari, Narayanan
    Wallace, Jan
    Barber, Jim
    Syndikus, Isabel
    Parmar, Mahesh K. B.
    Sydes, Matthew R.
    [J]. JAMA ONCOLOGY, 2016, 2 (03) : 348 - 357